Uncategorized
DRCR.net subgroup analysis: Long-term anti-VEGF decreases rate of chronic persistent DME
BOSTON — Continuing anti-VEGF treatment longer than 6 months decreased the rate of chronic persistent diabetic macular edema and slowed vision loss, according to a study presented here.At Macula 2015, Neil M. Bressler, MD, discussed a subgroup analysis of data culled from the DRCR.net Protocol I clinical trial.